Teva

Teva Pharmaceutical Industries Ltd., founded in 1901, is a prominent global biopharmaceutical leader dedicated to enhancing patient health outcomes worldwide. The company operates with a mission to improve lives through a comprehensive portfolio of medicines, encompassing complex generics, advanced biosimilars, innovative therapies, and trusted pharmacy brands. Teva's commitment extends to addressing critical unmet patient needs through rigorous scientific research and development, ensuring broader access to high-quality treatments. Meet Teva's team to understand the dedicated professionals driving these advancements.

With a significant global presence spanning 13 locations, Teva leverages its world-class generics business to deliver a wide array of pharmaceutical solutions. Its product offerings include essential generic medicines, specialty pharmaceuticals, and cutting-edge therapeutic interventions. The company focuses on streamlining the delivery of treatments, from established generic drugs to novel, complex formulations. Learn about Teva's global headquarters in Tel Aviv, Israel, which serves as the central hub for its extensive international operations. Teva employs over 10,000 individuals, contributing to its robust operational capacity and market reach.

Generating substantial revenue, Teva plays a critical role in the global healthcare landscape, competing with major industry players like Pfizer, Novartis, and Sun Pharma. The company's financial strategy involves significant debt financing to support its growth and operational expansion. Teva's dedication to innovation and accessibility is reflected in its broad product pipeline and its continuous efforts to advance pharmaceutical science. Explore financial highlights to gain deeper insights into its market performance and strategic investments.